Endocrine Metabolic Articles & Analysis

1 news found

RareStone Group & Rhythm Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China

Citrine Medicine currently focuses on four therapeutic areas: neuroscience, endocrine & metabolic diseases, liver & kidney diseases, and rare pediatric oncology. ...

Dec. 24, 2021

ByRareStone Group

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you